MOYES JAY M
MOYES JAY M's purchase track record
MOYES JAY M has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/23/2026 | SINT | $3K | -17.3% | -48.6% | +11.9% |
| 8/26/2025 | SINT | $11K | -4.1% | -21.9% | +6.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
SINTX Q3 Revenue Tops Guidance; Analyst Raises Target. SiNtx Technologies reported preliminary Q3 revenue of $2.2 million, significantly exceeding its previous guidance range of $0.9 million to $1.1 million. Following this update, Ascendiant Capital raised its price target to $12.50. This strong revenue performance stands out against the stock's 52-week range of $1.40 to $4.66.
Transaction History
| PBYI | ▼ Sell | Open Market | 22,000 | $159K | 6/12/2026 | View on chart |
| PBYI | ▲ Buy | Grant | 27,000 | $0 | 6/11/2026 | View on chart |
| SINT | ▲ Buy | Open Market | 1,000 | $3K | 2/23/2026 | View on chart |
| SINT | ▲ Buy | Open Market | 3,000 | $11K | 8/26/2025 | View on chart |
| PBYI | ▼ Sell | Open Market | 22,000 | $75K | 6/13/2025 | View on chart |
| PBYI | ▲ Buy | Grant | 27,000 | $0 | 6/11/2025 | View on chart |
| PBYI | ▲ Buy | Grant | 27,000 | $0 | 6/18/2024 | View on chart |
| PBYI | ▼ Sell | Open Market | 22,000 | $73K | 6/13/2024 | View on chart |
| PBYI | ▼ Sell | Open Market | 22,000 | $76K | 6/13/2023 | View on chart |
| PBYI | ▲ Buy | Grant | 27,000 | $0 | 6/13/2023 | View on chart |
| SERA | ▲ Buy | Grant | 32,800 | $0 | 3/6/2023 | View on chart |
| PBYI | ▼ Sell | Open Market | 22,858 | $60K | 6/16/2022 | View on chart |
| PBYI | ▲ Buy | Grant | 27,000 | $0 | 6/14/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Puma Biotechnology inducement award under Nasdaq Rule 5635(c)(4)
Puma Biotechnology disclosed that it received an inducement award in accordance with Nasdaq Listing Rule 5635(c)(4). The award is intended to assist the company in meeting Nasdaq's continued listing requirements. This filing is a regulatory update that informs investors of the company's compliance actions.
Puma Biotechnology inducement award under Nasdaq Rule 5635(c)(4). Puma Biotechnology disclosed that it received an inducement award in accordance with Nasdaq Listing Rule 5635(c)(4). The award is intended to assist the company in meeting Nasdaq's continued listing requirements. This filing is a regulatory update that informs investors of the company's compliance actions.